Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Heparin-associated thrombocytopenia

D B Cines, P Kaywin, M Bina

The New England Journal of Medicine

|October 2, 1980

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

An alternative and convenient strategy for generation of substantial quantities of singly 5'-32P-end-labeled double-stranded DNA for binding studies: development of a protocol for examination of functional features of (+)-CC-1065 and the duocarmycins that contribute to their sequence-selective DNA alkylation properties.

Tetrahedron·2018

Same author

A review of recent advances in the spherical harmonics expansion method for semiconductor device simulation.

Journal of computational electronics·2016

Same author

Dicke coupling by feasible local measurements at the superradiant quantum phase transition.

Physical review. E·2016

Same author

Experimental validation of a nonlinear μFE model based on cohesive-frictional plasticity for trabecular bone.

International journal for numerical methods in biomedical engineering·2015

Same author

Heparin enhances uptake of platelet factor 4/heparin complexes by monocytes and macrophages.

Journal of thrombosis and haemostasis : JTH·2015

Same author

Genetic and epigenetic profiling of CLL disease progression reveals limited somatic evolution and suggests a relationship to memory-cell development.

Blood cancer journal·2015

Heparin can cause immune-mediated platelet injury. This study shows heparin-induced thrombocytopenia involves IgG antibodies and complement activation, explaining why some patients develop this condition.

Area of Science:

Immunology
Hematology
Pharmacology

Background:

Heparin is a widely used anticoagulant.
Thrombocytopenia is a potential adverse effect of heparin therapy.
The precise mechanism of heparin-induced thrombocytopenia (HIT) requires further elucidation.

Observation:

Patients with heparin-induced thrombocytopenia exhibited elevated platelet-associated IgG and C3 levels.
Plasma from thrombocytopenic patients induced serotonin release from normal platelets in the presence of therapeutic heparin concentrations.
This reaction was dependent on IgG and the classical complement pathway.

Findings:

Patients without thrombocytopenia had normal platelet-associated IgG and C3.
Plasma from non-thrombocytopenic patients induced serotonin release only at heparin concentrations exceeding the therapeutic range.

Related Experiment Videos

In vitro addition of heparin to normal plasma did not induce platelet injury, suggesting a patient-specific immune response.

Implications:

Heparin administration can trigger complement-mediated platelet injury.
The dose-dependent nature of this immune response may explain the variable incidence of heparin-induced thrombocytopenia.
Understanding this mechanism is crucial for managing and preventing heparin-induced adverse events.